A pre-S gene chip to detect pre-S deletions in hepatitis B virus large surface antigen as a predictive marker for hepatoma risk in chronic hepatitis B virus carriers

J Biomed Sci. 2009 Sep 15;16(1):84. doi: 10.1186/1423-0127-16-84.

Abstract

Background: Chronic hepatitis B virus (HBV) infection is an important cause of hepatocellular carcinoma (HCC) worldwide. The pre-S1 and -S2 mutant large HBV surface antigen (LHBS), in which the pre-S1 and -S2 regions of the LHBS gene are partially deleted, are highly associated with HBV-related HCC.

Methods: The pre-S region of the LHBS gene in two hundred and one HBV-positive serum samples was PCR-amplified and sequenced. A pre-S oligonucleotide gene chip was developed to efficiently detect pre-S deletions in chronic HBV carriers. Twenty serum samples from chronic HBV carriers were analyzed using the chip.

Results: The pre-S deletion rates were relatively low (7%) in the sera of patients with acute HBV infection. They gradually increased in periods of persistent HBV infection: pre-S mutation rates were 37% in chronic HBV carriers, and as high as 60% in HCC patients. The Pre-S Gene Chip offers a highly sensitive and specific method for pre-S deletion detection and is less expensive and more efficient (turnaround time 3 days) than DNA sequencing analysis.

Conclusion: The pre-S1/2 mutants may emerge during the long-term persistence of the HBV genome in carriers and facilitate HCC development. Combined detection of pre-S mutations, other markers of HBV replication, and viral titers, offers a reliable predictive method for HCC risks in chronic HBV carriers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular / epidemiology*
  • Carcinoma, Hepatocellular / etiology
  • DNA Mutational Analysis / instrumentation*
  • DNA, Viral / blood
  • DNA, Viral / genetics*
  • Hepatitis B Antigens / genetics*
  • Hepatitis B virus / genetics*
  • Hepatitis B virus / pathogenicity
  • Hepatitis B, Chronic / blood
  • Hepatitis B, Chronic / virology*
  • Humans
  • Liver Neoplasms / epidemiology*
  • Liver Neoplasms / etiology
  • Mutation
  • Oligonucleotide Array Sequence Analysis*
  • Polymerase Chain Reaction
  • Predictive Value of Tests
  • Risk
  • Sequence Deletion
  • Viral Envelope Proteins / genetics*

Substances

  • DNA, Viral
  • Hepatitis B Antigens
  • L protein, hepatitis B virus
  • Viral Envelope Proteins